Lithium;3-[(1R)-1-aminoethyl]-5-(trifluoromethyl)aniline;4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylic acid;[4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-morpholin-4-ylmethanone;ethyl 4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;ethyl 4-chloro-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;morpholine;hydroxide
C80H90ClF12LiN22O10 — CID 164962680
Data last refreshed: (MolForge compound catalog, from PubChem)
About Lithium;3-[(1R)-1-aminoethyl]-5-(trifluoromethyl)aniline;4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylic acid;[4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-morpholin-4-ylmethanone;ethyl 4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;ethyl 4-chloro-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;morpholine;hydroxide
Lithium;3-[(1R)-1-aminoethyl]-5-(trifluoromethyl)aniline;4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylic acid;[4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-morpholin-4-ylmethanone;ethyl 4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;ethyl 4-chloro-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;morpholine;hydroxide (PubChem CID 164962680) has the molecular formula C80H90ClF12LiN22O10 and a molecular weight of 1790.11 g/mol. Its IUPAC name is lithium;3-[(1R)-1-aminoethyl]-5-(trifluoromethyl)aniline;4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylic acid;[4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-morpholin-4-ylmethanone;ethyl 4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;ethyl 4-chloro-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;morpholine;hydroxide.
Molecular Properties
| Compound Name | Lithium;3-[(1R)-1-aminoethyl]-5-(trifluoromethyl)aniline;4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylic acid;[4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-morpholin-4-ylmethanone;ethyl 4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;ethyl 4-chloro-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;morpholine;hydroxide |
|---|---|
| PubChem CID | 164962680 |
| Molecular Formula | C80H90ClF12LiN22O10 |
| Molecular Weight | 1790.11 g/mol |
| Exact Mass | 1788.69 |
| IUPAC Name | lithium;3-[(1R)-1-aminoethyl]-5-(trifluoromethyl)aniline;4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylic acid;[4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazin-2-yl]-morpholin-4-ylmethanone;ethyl 4-[[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]amino]-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;ethyl 4-chloro-6-methylpyrazolo[1,5-a]pyrazine-2-carboxylate;morpholine;hydroxide |
| SMILES | C1COCCN1.CCOC(=O)c1cc2c(Cl)nc(C)cn2n1.CCOC(=O)c1cc2c(N[C@H](C)c3cc(N)cc(C(F)(F)F)c3)nc(C)cn2n1.C[C@@H](N)c1cc(N)cc(C(F)(F)F)c1.Cc1cn2nc(C(=O)N3CCOCC3)cc2c(N[C@H](C)c2cc(N)cc(C(F)(F)F)c2)n1.Cc1cn2nc(C(=O)O)cc2c(N[C@H](C)c2cc(N)cc(C(F)(F)F)c2)n1.[Li+].[OH-] |
| InChI | InChI=1S/C21H23F3N6O2.C19H20F3N5O2.C17H16F3N5O2.C10H10ClN3O2.C9H11F3N2.C4H9NO.Li.H2O/c1-12-11-30-18(10-17(28-30)20(31)29-3-5-32-6-4-29)19(26-12)27-13(2)14-7-15(21(22,23)24)9-16(25)8-14;1-4-29-18(28)15-8-16-17(24-10(2)9-27(16)26-15)25-11(3)12-5-13(19(20,21)22)7-14(23)6-12;1-8-7-25-14(6-13(24-25)16(26)27)15(22-8)23-9(2)10-3-11(17(18,19)20)5-12(21)4-10;1-3-16-10(15)7-4-8-9(11)12-6(2)5-14(8)13-7;1-5(13)6-2-7(9(10,11)12)4-8(14)3-6;1-3-6-4-2-5-1;;/h7-11,13H,3-6,25H2,1-2H3,(H,26,27);5-9,11H,4,23H2,1-3H3,(H,24,25);3-7,9H,21H2,1-2H3,(H,22,23)(H,26,27);4-5H,3H2,1-2H3;2-5H,13-14H2,1H3;5H,1-4H2;;1H2/q;;;;;;+1;/p-1/t13-;11-;9-;;5-;;;/m111.1.../s1 |
| InChIKey | CBBXUFWDARAUNN-GBGDWNLISA-M |
| XLogP | 11.39 |
| TPSA | 457.65 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 126 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1790.11 |
| LogP ≤ 5 | 11.39 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 30 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164962680 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.